When intestinal epithelial cells are damaged or stimulated by inflammation, the NF-κB pathway is activated, promoting the expression of inflammatory cytokines that can enhance the proliferation, survival, and angiogenesis of tumor cells, thereby playing a role in the progression of CRC [90]. The gene discussed is NFKB1; the disease is colorectal carcinoma.